Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes (TDE)
Diabetes Mellitus, Type 2

About this trial
This is an interventional prevention trial for Diabetes Mellitus, Type 2 focused on measuring predictive genomics, personalized medicine, personal genomics, genetic knowledge, genetic attitudes, prevention, health outcomes, behavioral
Eligibility Criteria
Inclusion Criteria:
- Are male or female outpatients
- No self-reported history of diabetes
- No self-reported history of prior genetic testing for diabetes
- Not pregnant (self report)
- Are ≥18 and <81 years of age
- Scheduled to receive serum glucose test in participating clinic
- Fasting at time of blood draw (no food or drink - except water - previous 8 hours: self report)
- Able and willing to give legally effective consent
- Able and willing to participate in patient questionnaires
- Ambulatory
Exclusion Criteria:
- Previously or currently taking medications for lowering glucose (i.e., exenatide, pramlintide, metformin, rosiglitazone, pioglitazone, or future diabetes drugs) based on self-report and/or prescreening
- Self-report of current or prior diabetes diagnosis
- Self-reported prior history of genetic testing for diabetes
- Baseline serum glucose test result >125
Sites / Locations
- Duke Family Medicine at Pickens
- Duke Health Center at Pickett Rd
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
No Intervention
No Intervention
SRA+genetic test
SRA only
no testing control
patients randomized to receive genetic test for type 2 diabetes risk will be followed and surveyed and will be counseled based on SAR and genetic risk for type 2 diabetes
Patients randomized to not get genetic testing will be followed and surveyed and will be counseled based on SRA only
Patients not interested in genetic testing will be followed and surveyed. Counseling will be based on SRA only